Procter & Gamble 2000 (A): The SpinBrush and Innovation at P&G Custom Case Solution & Analysis

1. Evidence Brief (Case Researcher)

Financial Metrics

SpinBrush retail price: $5.99 (Exhibit 1).
Estimated manufacturing cost: $1.50–$2.00 (implied by target margins).
P&G category growth targets: 5%–7% (Paragraph 3).
Projected annual sales for SpinBrush: $200M (Paragraph 12).

Operational Facts

Development cycle: 6 months from acquisition to shelf (Paragraph 15).
Distribution: Mass market retail (Wal-Mart, CVS, etc.) (Exhibit 2).
Acquisition target: Dr. John Osher and his company, Den-Mat (Paragraph 8).
Manufacturing: Outsourced to low-cost providers in China (Paragraph 11).

Stakeholder Positions

John Pepper (CEO): Pushing for Innovation and speed (Paragraph 2).
A.G. Lafley (Incoming CEO): Focused on core brands and organic growth (Paragraph 4).
Internal P&G R&D: Historically accustomed to 3–5 year development cycles (Paragraph 6).

Information Gaps

Specific breakdown of R&D overhead allocation for new ventures.
Cannibalization rates of existing Crest manual brush lines.
Long-term supply chain agreements with Chinese manufacturers.

2. Strategic Analysis (Strategic Analyst)

Core Strategic Question

Should P&G integrate the SpinBrush acquisition into its traditional, high-process R&D structure, or maintain it as an autonomous, agile unit to disrupt the oral care category?

Structural Analysis

Value Chain: P&G’s internal value chain is built for high-margin, long-term brand equity. SpinBrush is a low-margin, high-volume commodity. Integrating the two will introduce unnecessary friction.
Ansoff Matrix: This is a product development strategy within existing markets. P&G is using acquisition to bypass its own slow innovation cycle.

Strategic Options

Option 1: Full Integration. Absorb SpinBrush into the Oral Care division. Trade-off: Ensures brand consistency but subjects the product to P&G’s 3-year cycle, killing the speed advantage.
Option 2: Autonomous Unit. Keep the SpinBrush team separate. Trade-off: Preserves agility and speed to market, but risks cultural friction with P&G headquarters.
Option 3: Divestment/Partnership. License the technology to a third party. Trade-off: Immediate cash, but abandons the opportunity to own the high-growth electric brush segment.

Preliminary Recommendation

Adopt Option 2. The competitive advantage of the SpinBrush is its speed. Applying P&G’s standard development processes would destroy the product's primary value driver.

3. Implementation Roadmap (Implementation Specialist)

Critical Path

Month 1–3: Establish the autonomous unit reporting directly to the Group President. Retain key personnel from the acquisition.
Month 4–6: Stabilize the supply chain in China. Move from pilot production to mass-scale manufacturing.
Month 7–9: Roll out to top-tier national retailers using P&G’s shelf-space clout.

Key Constraints

Cultural Mismatch: P&G’s risk-averse culture will attempt to bureaucratize the SpinBrush team.
Supply Chain Stability: Reliance on Chinese manufacturing requires rigorous quality control that the current team may not be prepared for.

Risk-Adjusted Implementation Strategy

Create a firewall between the SpinBrush unit and P&G’s core R&D. Use a separate P&L. If the unit fails to hit $100M revenue by Month 12, trigger a pre-planned integration into the standard Oral Care division.

4. Executive Review and BLUF (Executive Critic)

BLUF

P&G must operate SpinBrush as an autonomous entity. The company’s core innovation process is too slow to support the rapid-cycle, low-margin model required for this product. If P&G attempts to standardize SpinBrush under its current R&D protocols, the product will fail to capture the market before competitors respond. The goal is not to preserve P&G culture, but to capture the $200M segment. If the unit cannot function independently, it is better to divest than to integrate and watch it die in the bureaucracy.

Dangerous Assumption

The analysis assumes P&G can effectively manage an autonomous unit without that unit eventually being cannibalized by internal political pressure to conform to corporate standards.

Unaddressed Risks

Cannibalization: The potential for SpinBrush to erode sales of higher-margin Crest manual toothbrushes is not quantified.
Retailer Backlash: If P&G uses its market power to force SpinBrush into stores, it risks alienating retail partners who depend on the margins of more expensive, established electric brushes.

Unconsidered Alternative

A joint venture with the original developers, keeping them as minority stakeholders to maintain their incentive to keep the product cycle short, rather than an outright acquisition.